Since its discovery in 2001 [8], the biological effects of resistin and its association with various pathological processes such as insulin resistance [9], vascular smooth muscle cell proliferation [10], endothelial dysfunction, reduced nitric oxide (NO) bioavailability [11] and atherosclerosis [12] has been extensively investigated. This evidence concerns the gene RETN and atherosclerosis.